Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Rimantadine (generic, formerly branded as Flumadine) and amantadine (generic, formerly branded as Symmetrel) are both oral medications, but they serve different purposes and belong to different drug classes. Rimantadine is an antiviral used to treat and prevent influenza type A, while amantadine is an NMDA antagonist used to manage symptoms of Parkinson's disease and other movement disorders. Rimantadine works by preventing the influenza virus from replicating, whereas amantadine increases dopamine levels to help with movement coordination. Rimantadine is typically taken twice a day, while amantadine can be taken once or twice daily. Common side effects for both include nausea, dizziness, and trouble sleeping, but amantadine also carries risks of mood changes and hallucinations. Additionally, rimantadine is not recommended for use due to resistance in flu strains, whereas amantadine is still commonly used for its indications.
Rimantadine
Amantadine
Rimantadine
Amantadine
Summary of Rimantadine vs. Symmetrel
Summary for Antiviral
Prescription only
Rimantadine is an antiviral used to treat influenza A in adults, and prevent influenza A in children and adults. But rimantadine hasn't been a recommended option in recent years because many strains of flu virus have become resistant to this medication. Rimantadine is taken by mouth, typically twice a day. Side effects aren't common, but can include nausea, trouble sleeping, and dizziness. The brand name Flumadine has been discontinued so it's only available as a generic.
Summary for NMDA antagonist
Prescription only
Amantadine is an NMDA antagonist. It's used to treat symptoms of movement disorders in adults, including Parkinson’s disease (PD). It works by raising the levels of dopamine in your body, which helps coordinate movements. Amantadine is taken by mouth, typically once or twice daily. Some side effects of this medication include nausea, dizziness, and trouble sleeping.
Indications of Rimantadine vs. Symmetrel
Indications for
•Treatment of influenza type A - adults ages 17 and older
•Prevention of influenza type A - people ages 1 year and older